220 related articles for article (PubMed ID: 26130695)
21. Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India.
Hedau S; Jain N; Husain SA; Mandal AK; Ray G; Shahid M; Kant R; Gupta V; Shukla NK; Deo SS; Das BC
Breast Cancer Res Treat; 2004 Nov; 88(2):177-86. PubMed ID: 15564800
[TBL] [Abstract][Full Text] [Related]
22. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.
Singh V; Rastogi N; Sinha A; Kumar A; Mathur N; Singh MP
Breast Cancer Res Treat; 2007 Jan; 101(1):73-81. PubMed ID: 16807674
[TBL] [Abstract][Full Text] [Related]
23. Individuals with FANCM biallelic mutations do not develop Fanconi anemia, but show risk for breast cancer, chemotherapy toxicity and may display chromosome fragility.
Catucci I; Osorio A; Arver B; Neidhardt G; Bogliolo M; Zanardi F; Riboni M; Minardi S; Pujol R; Azzollini J; Peissel B; Manoukian S; De Vecchi G; Casola S; Hauke J; Richters L; Rhiem K; Schmutzler RK; Wallander K; Törngren T; Borg Å; Radice P; Surrallés J; Hahnen E; Ehrencrona H; Kvist A; Benitez J; Peterlongo P
Genet Med; 2018 Apr; 20(4):452-457. PubMed ID: 28837162
[TBL] [Abstract][Full Text] [Related]
24. DNA-repair genetic polymorphisms and breast cancer risk.
Smith TR; Levine EA; Perrier ND; Miller MS; Freimanis RI; Lohman K; Case LD; Xu J; Mohrenweiser HW; Hu JJ
Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1200-4. PubMed ID: 14652281
[TBL] [Abstract][Full Text] [Related]
25. Case-control analysis of truncating mutations in DNA damage response genes connects TEX15 and FANCD2 with hereditary breast cancer susceptibility.
Mantere T; Tervasmäki A; Nurmi A; Rapakko K; Kauppila S; Tang J; Schleutker J; Kallioniemi A; Hartikainen JM; Mannermaa A; Nieminen P; Hanhisalo R; Lehto S; Suvanto M; Grip M; Jukkola-Vuorinen A; Tengström M; Auvinen P; Kvist A; Borg Å; Blomqvist C; Aittomäki K; Greenberg RA; Winqvist R; Nevanlinna H; Pylkäs K
Sci Rep; 2017 Apr; 7(1):681. PubMed ID: 28386063
[TBL] [Abstract][Full Text] [Related]
26. Interaction of Werner and Bloom syndrome genes with p53 in familial breast cancer.
Wirtenberger M; Frank B; Hemminki K; Klaes R; Schmutzler RK; Wappenschmidt B; Meindl A; Kiechle M; Arnold N; Weber BH; Niederacher D; Bartram CR; Burwinkel B
Carcinogenesis; 2006 Aug; 27(8):1655-60. PubMed ID: 16501249
[TBL] [Abstract][Full Text] [Related]
27. Mutation analysis of FANCD2, BRIP1/BACH1, LMO4 and SFN in familial breast cancer.
Lewis AG; Flanagan J; Marsh A; Pupo GM; Mann G; Spurdle AB; Lindeman GJ; Visvader JE; Brown MA; Chenevix-Trench G;
Breast Cancer Res; 2005; 7(6):R1005-16. PubMed ID: 16280053
[TBL] [Abstract][Full Text] [Related]
28. A population-based case-control study of the Arg399Gln polymorphism in DNA repair gene XRCC1 and risk of breast cancer.
Shu XO; Cai Q; Gao YT; Wen W; Jin F; Zheng W
Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1462-7. PubMed ID: 14693738
[TBL] [Abstract][Full Text] [Related]
29. A common nonsense mutation of the BLM gene and prostate cancer risk and survival.
Antczak A; Kluźniak W; Wokołorczyk D; Kashyap A; Jakubowska A; Gronwald J; Huzarski T; Byrski T; Dębniak T; Masojć B; Górski B; Gromowski T; Nagorna A; Gołąb A; Sikorski A; Słojewski M; Gliniewicz B; Borkowski T; Borkowski A; Przybyła J; Sosnowski M; Małkiewicz B; Zdrojowy R; Sikorska-Radek P; Matych J; Wilkosz J; Różański W; Kiś J; Bar K; Domagała P; Stawicka M; Milecki P; Akbari MR; Narod SA; Lubiński J; Cybulski C; ; ; Bryniarski P; Paradysz A; Jersak K; Niemirowicz J; Słupski P; Jarzemski P; Skrzypczyk M; Dobruch J; Domagała W; Chosia M; van de Wetering T; Serrano-Fernández P; Puszyński M; Soczawa M; Switała J; Archimowicz S; Kordowski M; Zyczkowski M; Borówka A; Bagińska J; Krajka K; Szwiec M; Haus O; Janiszewska H; Stembalska A; Sąsiadek MM
Gene; 2013 Dec; 532(2):173-6. PubMed ID: 24096176
[TBL] [Abstract][Full Text] [Related]
30. Polymorphisms in XRCC1 modify the association between polycyclic aromatic hydrocarbon-DNA adducts, cigarette smoking, dietary antioxidants, and breast cancer risk.
Shen J; Gammon MD; Terry MB; Wang L; Wang Q; Zhang F; Teitelbaum SL; Eng SM; Sagiv SK; Gaudet MM; Neugut AI; Santella RM
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):336-42. PubMed ID: 15734955
[TBL] [Abstract][Full Text] [Related]
31. FANCM missense variants and breast cancer risk: a case-control association study of 75,156 European women.
Figlioli G; Billaud A; Ahearn TU; Antonenkova NN; Becher H; Beckmann MW; Behrens S; Benitez J; Bermisheva M; Blok MJ; Bogdanova NV; Bonanni B; Burwinkel B; Camp NJ; Campbell A; Castelao JE; Cessna MH; Chanock SJ; ; Czene K; Devilee P; Dörk T; Engel C; Eriksson M; Fasching PA; Figueroa JD; Gabrielson M; Gago-Dominguez M; García-Closas M; González-Neira A; Grassmann F; Guénel P; Gündert M; Hadjisavvas A; Hahnen E; Hall P; Hamann U; Harrington PA; He W; Hillemanns P; Hollestelle A; Hooning MJ; Hoppe R; Howell A; Humphreys K; ; Jager A; Jakubowska A; Khusnutdinova EK; Ko YD; Kristensen VN; Lindblom A; Lissowska J; Lubiński J; Mannermaa A; Manoukian S; Margolin S; Mavroudis D; Newman WG; Obi N; Panayiotidis MI; Rashid MU; Rhenius V; Rookus MA; Saloustros E; Sawyer EJ; Schmutzler RK; Shah M; Sironen R; Southey MC; Suvanto M; Tollenaar RAEM; Tomlinson I; Truong T; van der Kolk LE; van Veen EM; Wappenschmidt B; Yang XR; Bolla MK; Dennis J; Dunning AM; Easton DF; Lush M; Michailidou K; Pharoah PDP; Wang Q; Adank MA; Schmidt MK; Andrulis IL; Chang-Claude J; Nevanlinna H; Chenevix-Trench G; Evans DG; Milne RL; Radice P; Peterlongo P
Eur J Hum Genet; 2023 May; 31(5):578-587. PubMed ID: 36707629
[TBL] [Abstract][Full Text] [Related]
32. Breast cancer risk associated with genotypic polymorphism of the nonhomologous end-joining genes: a multigenic study on cancer susceptibility.
Fu YP; Yu JC; Cheng TC; Lou MA; Hsu GC; Wu CY; Chen ST; Wu HS; Wu PE; Shen CY
Cancer Res; 2003 May; 63(10):2440-6. PubMed ID: 12750264
[TBL] [Abstract][Full Text] [Related]
33. Single nucleotide polymorphisms in the XPG gene: determination of role in DNA repair and breast cancer risk.
Kumar R; Höglund L; Zhao C; Försti A; Snellman E; Hemminki K
Int J Cancer; 2003 Feb; 103(5):671-5. PubMed ID: 12494477
[TBL] [Abstract][Full Text] [Related]
34. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
Durocher F; Labrie Y; Soucy P; Sinilnikova O; Labuda D; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Ouellette G; Pichette R; Plante M; Tavtigian SV; Simard J
BMC Cancer; 2006 Sep; 6():230. PubMed ID: 17010193
[TBL] [Abstract][Full Text] [Related]
35. Contribution of mutations in ATM to breast cancer development in the Czech population.
Soukupova J; Dundr P; Kleibl Z; Pohlreich P
Oncol Rep; 2008 Jun; 19(6):1505-10. PubMed ID: 18497957
[TBL] [Abstract][Full Text] [Related]
36. Contribution of DNA Double-strand Break Repair Gene XRCC3 Genotypes to Triple-negative Breast Cancer Risk.
Su CH; Chang WS; Hu PS; Hsiao CL; Ji HX; Liao CH; Yueh TC; Chuang CL; Tsai CW; Hsu CM; Lane HY; Bau DT
Cancer Genomics Proteomics; 2015; 12(6):359-67. PubMed ID: 26543082
[TBL] [Abstract][Full Text] [Related]
37. Polymorphisms in XPD exons 10 and 23 and bladder cancer risk.
Schabath MB; Delclos GL; Grossman HB; Wang Y; Lerner SP; Chamberlain RM; Spitz MR; Wu X
Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):878-84. PubMed ID: 15824159
[TBL] [Abstract][Full Text] [Related]
38. Association of rare MSH6 variants with familial breast cancer.
Wasielewski M; Riaz M; Vermeulen J; van den Ouweland A; Labrijn-Marks I; Olmer R; van der Spaa L; Klijn JG; Meijers-Heijboer H; Dooijes D; Schutte M
Breast Cancer Res Treat; 2010 Sep; 123(2):315-20. PubMed ID: 19924528
[TBL] [Abstract][Full Text] [Related]
39. A role for XRCC4 in age at diagnosis and breast cancer risk.
Allen-Brady K; Cannon-Albright LA; Neuhausen SL; Camp NJ
Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1306-10. PubMed ID: 16835328
[TBL] [Abstract][Full Text] [Related]
40. DNA repair gene X-ray repair cross-complementing group 1 and xeroderma pigmentosum group D polymorphisms and risk of prostate cancer: a study from North India.
Mandal RK; Gangwar R; Mandhani A; Mittal RD
DNA Cell Biol; 2010 Apr; 29(4):183-90. PubMed ID: 20070155
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
